Effect of long-term anticonvulsant therapy on glucose metabolism in humans.
This study was undertaken to evaluate the effect of anticonvulsants on glucose metabolism in humans. Tissue sensitivity to insulin (euglycemic clamp technique) and liver microsomal enzyme activity (oral antipyrine test) were measured in six subjects with epilepsy plus type 1 diabetes mellitus. They had received anticonvulsant drugs for greater than 8 years. Three groups--type 1 diabetics, persons with epilepsy, and healthy subjects--matched for sex, and weight, served as controls. Glucose disposal rate (M) was faster in subjects on anticonvulsant therapy as compared with the corresponding control group (p less than 0.01) and in nondiabetics as compared with diabetics (p less than 0.001). Antipyrine metabolism was rapid among patients on anticonvulsants and high normal in diabetics. Liver microsomal enzyme activity and glucose metabolism were related among diabetic (r = 0.593) and nondiabetic (r = 0.649) groups, respectively. Anticonvulsants with liver microsomal enzyme-inducing properties appear to enhance insulin sensitivity. These findings may serve to understand the long-term effect of anticonvulsants on glucose metabolism in humans.
D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000378:metabolism* / Q000627:therapeutic use; D000983:Antipyrine / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism*; D004790:Enzyme Induction; D004827:Epilepsy / Q000378:metabolism*; D005260:Female; D006801:Humans; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000096:biosynthesis; D013997:Time Factors
D000927:Anticonvulsants; D001786:Blood Glucose; D007328:Insulin; D006899:Mixed Function Oxygenases; D000983:Antipyrine